Stay updated on Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page
- Check3 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study details for this record and indicating the record is currently inaccessible.SummaryDifference17%

- Check10 days agoChange DetectedA new site revision tag is displayed: Revision: v3.7.0 replaces Revision: v3.6.6. This appears to reflect a software version update in the page footer and does not change the study content or data.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe revision tag on the page has been updated from Revision: v3.6.5 to Revision: v3.6.6, indicating a minor template or backend update.SummaryDifference0.1%

- Check38 days agoChange DetectedA full bibliographic citation for a SARS-related study was added, and the page revision was updated to v3.6.5. The corresponding shorter citation and the older revision tag v3.6.4 were removed.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page's revision tag updated from v3.6.3 to v3.6.4, indicating a small template/system update for the study record page.SummaryDifference0.1%

- Check73 days agoChange DetectedThe citation for the Respiratory Research article is updated to correct the volume/issue formatting from 6(1):5 to 6:5.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page.